TWi Pharma Launches Generics in US

TWi Pharmaceuticals, Inc., through its wholly owned subsidiary TWi Pharmaceuticals USA, shipped the first generic products under its own label in the U.S. market. According to the company, this makes TWi the first Taiwanese pharmaceutical company to directly sell generic pharmaceutical products under its own label in the U.S.

“Since forming TWi Pharmaceuticals USA in January 2014, we have focused our efforts on this launch in order to establish our presence in the U.S. market. While this is an important milestone, it is only the first of many more to come,” said Tina Guilder, president of TWi Pharmaceuticals USA. “I’m proud that our team has the distinct honor of being the first Taiwanese company to bring high-quality generic products to our customers and patients in the U.S.”